Meeting
2016 ASCO Annual Meeting
Clinicopathological features of program death ligand-1 (PD-L1) expression with tumor-infiltrating lymphocytes (TILs), mismatch repair (MMR) and Epstein-Barr virus (EBV) status in a large cohort of gastric cancer.
Authors
Akihito Kawazoe
Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan
Akihito Kawazoe , Takeshi Kuwata , Yasutoshi Kuboki , Kohei Shitara , Akiko Nagatsuma , Takayuki Yoshino , Toshihiko Doi , Atsushi Ohtsu , Atsushi Ochiai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4053)
DOI
10.1200/JCO.2016.34.15_suppl.4053
Abstract #
4053
Poster Bd #
45
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
Correlation of PD-L1 expression with immune cell infiltrates, genome-wide copy number aberrations and survival in mesothelioma.
First Author: Bibhusal Thapa
Poster
2015 ASCO Annual Meeting
Prognostic significance of tumor infiltrating immune cells and PD-L1 expression in gastric carcinoma in Chinese patients.
First Author: Ruixuan Geng
Poster
2022 ASCO Annual Meeting
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach.
First Author: Marie Cumberbatch
Poster
2019 Genitourinary Cancers Symposium
Immune infiltrate with CD8 low or PDL1 high associated with metastatic prostate cancer after radical prostatectomy (RP).
First Author: Cecile Vicier